共 13 条
- [1] BATTELI J, 1982, P INT S MEDROXYPROGE, P397
- [2] TAMOXIFEN AS A POSSIBLE CHEMOTHERAPEUTIC AGENT IN ENDOMETRIAL ADENOCARCINOMA[J]. GYNECOLOGIC ONCOLOGY, 1981, 11 (02) : 140 - 161BONTE, JIDE, PBILLIET, GWYNANTS, P
- [3] BOULIEU EE, 1983, STEROIDS ENDOMETRIAL, P61
- [4] TAMOXIFEN AND ENDOMETRIAL CARCINOMA - ALTERATIONS IN ESTROGEN AND PROGESTERONE RECEPTORS IN UNTREATED PATIENTS AND COMBINATION HORMONAL-THERAPY IN ADVANCED NEOPLASIA[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (02) : 149 - 153CARLSON, JAALLEGRA, JCDAY, TGWITTLIFF, JL
- [5] EDMONSON JH, 1986, CANCER TREAT REP, V70, P1019
- [6] Hald I, 1983, Eur J Gynaecol Oncol, V4, P83
- [7] ENDOMETRIAL CARCINOMA - STEROID-RECEPTORS AND RESPONSE TO MEDROXYPROGESTERONE ACETATE[J]. GYNECOLOGIC ONCOLOGY, 1985, 21 (03) : 314 - 319QUINN, MACAUCHI, MFORTUNE, D
- [8] QUINN MA, 1983, RECENT CLIN DEV GYNE, P93
- [9] TAMOXIFEN AND MEDROXYPROGESTERONE THERAPY FOR ADVANCED ENDOMETRIAL CARCINOMA[J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1984, 17 (04): : 285 - 291RENDINA, GMDONADIO, CFABRI, MMAZZONI, PNAZZICONE, P
- [10] SLAVIK M, 1984, CANCER TREAT REP, V68, P809